JOSELIN LEYVA: Open Payments
NPI 1770052797 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 11 payments from 7 companies in 2025. Trend: 2023 $334 · 2024 $325 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $97 |
| Daiichi Sankyo Inc. | 3 | $82 |
| TerSera Therapeutics LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $18 |
Products named: DARZALEX, Enhertu, DATROWAY, Zoladex, GEMTESA, MONOFERRIC, LYNOZYFIC, RYBREVANT.
Industry payments across FL — which companies pay providers there.
